Major adverse cardiac events and drug-coated balloon size in coronary interventions

OBJECTIVE: In-stent restenosis (ISR) is a feared complication after coronary stent implantation. Drug-coated balloon (DCB) is being promoted as a treatment option for ISR. However, the benefit-risk ratio of DCB length has not been investigated. Longer DCBs release more anti-proliferative drug to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Naguib, David, Knoop, Betül, Dannenberg, Lisa, Liebsch, Eva, Pöhl, Martin, Helten, Carolin, Assadi-Schmidt, Athena, Kelm, Malte, Zeus, Tobias, Polzin, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998862/
https://www.ncbi.nlm.nih.gov/pubmed/29848922
http://dx.doi.org/10.14744/AnatolJCardiol.2018.67864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998862/
https://www.ncbi.nlm.nih.gov/pubmed/29848922
http://dx.doi.org/10.14744/AnatolJCardiol.2018.67864

Ejemplares similares